Log In

Term Description

Therapy to which the interaction of specific genetic variants that are identified is known to confer synergy.

LOINC Names Get Info

Fully-Specified Name
Treatment to which interaction between genetic variants confers synergy:Prid:Pt:Bld/Tiss:Nom:
Long Common Name
Treatment to which interaction between genetic variants confers synergy [Identifier] in Blood or Tissue Nominal
Short Name
Variant interaction assoc therapy syner
Display Name
Treatment to which interaction between genetic variants confers synergy Nom (Bld/Tiss)
Consumer Name Alpha Get Info
Treatment to which interaction between genetic variants confers synergy, Blood or tissue specimen

Part Model Get Info

  • Component
    Treatment to which interaction between genetic variants confers synergy
    LP411096-3
    • Analyte
      Treatment to which interaction between genetic variants confers synergy
      LP411096-3
      • Component Numerator
        Treatment to which interaction between genetic variants confers synergy
        LP411096-3
        • Component Numerator Core
          Treatment to which interaction between genetic variants confers synergy
          LP411096-3
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Prid
    LP6850-4
  • Time
    Pt
    LP6960-1
  • System
    Bld/Tiss
    LP7061-7
    • System Core
      Bld/Tiss
      LP7061-7
    • Super System
      NULL
       
  • Scale
    Nom
    LP7750-5
  • Method
    NULL
     

Example Answer List: LL5374-5

Source: Quest Diagnostics Inc.
AnswerCodeScoreAnswer ID
BinimetinibLA30251-5
ImatinibLA30253-1
SunitinibLA30250-7
TrametinibLA30252-3
MidostaurinLA30247-3
SorafenibLA30248-1
PonatinibLA30249-9

Basic Attributes

Class
MOLPATH
Type
Laboratory
First Released
Version 2.67
Last Updated
Version 2.67 (ADD)
Order vs. Observation
Observation

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Léčba u níž interakce mezi genetickými variantami působí synergický efekt:Přítomnost nebo identita:Časový bod:Krev/tkáň:Nominální:
el-GRGreek (Greece)Θεραπεία στην οποία η αλληλεπίδραση μεταξύ γενετικών παραλλαγών δημιουργεί συνέργεια:Prid:Pt:Αίμα/Ιστός:Nom:
Synonyms: MOLPATH Nom Prid Pt Αίμα Αίμα/Ιστός Θεραπεία στην οποία η αλληλεπίδραση μεταξύ γενετικών παραλλαγών δημιουργεί συνέργεια Ιστός
es-ESSpanish (Spain)Tratamiento al que la interacción entre variantes genéticas confiere sinergia:Presencia o identidad:Punto temporal:Sangre o tejido:Nom:
es-MXSpanish (Mexico)Tratamiento al que la interacción entre variantes genéticas confiere sinergia:Presencia o identidad:Punto temporal:Sangre o tejido:Nominal:
fr-FRFrench (France)Traitement pour interaction entre variants génétiques provoquant une synergie:Identification:Ponctuel:Sang/Tissu:Résultat nominal:
it-ITItalian (Italy)Trattamento a cui l'interazione tra varianti genetiche conferisce sinergia:Prid:Pt:Sangue/Tess:Nom:
Synonyms: Patologia molecolare Presenza o Identità Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & Strisci
zh-CNChinese (China)因为遗传变异之间的相互作用而导致协同的治疗:存在与否或特征标识:时间点:全血/组织:名义型:
Synonyms: 全血或组织;血液/组织;血液或组织 分子病理学;分子病理学试验 分类型应答;分类型结果;名义性;名称型;名词型;名词性;标称性;没有自然次序的名义型或分类型应答 因为（因）遗传变异（遗传性变异、基因变异、传性变型、遗传变异体、基因变异体）之间的相互作用而导致（造成、带来、赋予、造就、致使）协同（协同效应）的治疗（治疗方法、治疗方法） 存在;存在与否;特征标识;身份;身份标识 时刻;随机;随意;瞬间 未作说明的组织;组织;组织 & 涂片 血;血液

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=93343-2